These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7378085

  • 1. Connective tissue activation. XV. Stimulation of glycosaminoglycan and DNA synthesis by a polymorphonuclear leukocyte factor.
    Myers SL, Castor CW.
    Arthritis Rheum; 1980 May; 23(5):556-63. PubMed ID: 7378085
    [Abstract] [Full Text] [Related]

  • 2. Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator.
    Castor CW, Ritchie JC, Williams CH, Scott ME, Whitney SL, Myers SL, Sloan TB, Anderson BE.
    Arthritis Rheum; 1979 Mar; 22(3):260-72. PubMed ID: 420716
    [Abstract] [Full Text] [Related]

  • 3. Connective tissue activation. XI. Stimulation of glycosaminoglycan and DNA formation by a platelet factor.
    Castor CW, Ritchie JC, Scott ME, Whitney SL.
    Arthritis Rheum; 1977 Apr; 20(3):859-68. PubMed ID: 856217
    [Abstract] [Full Text] [Related]

  • 4. Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor.
    Castor CW, Miller JW, Walz DA.
    Proc Natl Acad Sci U S A; 1983 Feb; 80(3):765-9. PubMed ID: 6572368
    [Abstract] [Full Text] [Related]

  • 5. Connective tissue activation. XXVIII. A connective tissue activating peptide from human urine.
    Gordon MA, Hollenberg MD, Castor CW.
    Arthritis Rheum; 1984 Jul; 27(7):780-8. PubMed ID: 6611161
    [Abstract] [Full Text] [Related]

  • 6. Connective tissue activation. XXII. A platelet growth factor (connective tissue-activating peptide-III) in human growth hormone-deficient patients.
    Castor CW, Cobel-Geard SR, Hossler PA, Kelch RP.
    J Clin Endocrinol Metab; 1981 Jan; 52(1):128-32. PubMed ID: 6778888
    [Abstract] [Full Text] [Related]

  • 7. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
    Castor CW, Smith EM, Hossler PA, Bignall MC, Aaron BP.
    Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
    [Abstract] [Full Text] [Related]

  • 8. Connective tissue activation XXVI: IgG stimulation of glycosaminoglycan synthesis in human synovial cultures.
    Miller JW, Castor CW.
    J Rheumatol; 1983 Apr; 10(2):190-6. PubMed ID: 6408255
    [Abstract] [Full Text] [Related]

  • 9. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
    Castor CW, Smith EM, Bignall MC, Hossler PA.
    J Rheumatol; 1997 Nov; 24(11):2080-9. PubMed ID: 9375864
    [Abstract] [Full Text] [Related]

  • 10. Connective tissue activation. XXXII. Structural and biologic characteristics of mesenchymal cell-derived connective tissue activating peptide-V.
    Cabral AR, Cole LA, Walz DA, Castor CW.
    Arthritis Rheum; 1987 Dec; 30(12):1393-400. PubMed ID: 3124861
    [Abstract] [Full Text] [Related]

  • 11. Connective tissue activation. XIII. Stimulation of sulfated glycosaminoglycan synthesis in human connective tissue cells by peptide mediators from lymphocytes and platelets.
    Castor CW, Whitney SL.
    J Lab Clin Med; 1978 May; 91(5):811-21. PubMed ID: 641404
    [Abstract] [Full Text] [Related]

  • 12. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
    Castor CW, Andrews PC, Swartz RD, Ellis SG, Hossler PA, Clark MR, Matteson EL, Sachter EF.
    Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Connective tissue activation. XXV. Regulation of proteoglycan synthesis in human synovial cells.
    Castor CW, Roberts DJ, Hossler PA, Bignall MC.
    Arthritis Rheum; 1983 Apr; 26(4):522-7. PubMed ID: 6838674
    [Abstract] [Full Text] [Related]

  • 15. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
    Tai PK, Liao JF, Hossler PA, Castor CW, Carter-Su C.
    J Biol Chem; 1992 Sep 25; 267(27):19579-86. PubMed ID: 1527075
    [Abstract] [Full Text] [Related]

  • 16. Connective tissue activation. XVII. Radioimmunoassay of a human platelet derived connective tissue activating peptide (CTAP-III) and specificities of anti-CTAP-III sera.
    Weiss JJ, Meyers S, Castor CW, Donakowski C, Anderson B.
    Clin Chim Acta; 1980 Dec 22; 108(3):425-33. PubMed ID: 7471473
    [Abstract] [Full Text] [Related]

  • 17. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
    Castor CW, Walz DA, Johnson PH, Hossler PA, Smith EM, Bignall MC, Aaron BP, Underhill P, Lazar JM, Hudson DH.
    J Lab Clin Med; 1990 Oct 22; 116(4):516-26. PubMed ID: 2212861
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Connective tissue activation. XXI. Regulation of glycosaminoglycan metabolism by lymphocyte (CTAP-I) and platelet (CTAP-III) growth factors.
    Castor CW, Bignall MC, Hossler PA, Roberts DJ.
    In Vitro; 1981 Sep 22; 17(9):777-85. PubMed ID: 7298057
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.